'N-(2-chloro-6-methylphenyl)-2-[[(6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamides metabolites
AssigneeBristol-Myers Squibb Company
InventorsVinod Kumar Arora, Lisa Joy Christopher, Donghui Cui, Wenying Li
Life of this patent
Estimating the term…
Abstract
The present invention is directed to metabolites of ′N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, the compound of formula (I), pharmaceutical compositions thereof, and to methods of using the metabolites and the pharmaceutical compositions in the treatment of oncological and immunological disorders.
Claims10
A substantially pure compound of formula (II),
- or a pharmaceutically acceptable salt form thereof.
A substantially pure compound of formula (III),
- or a pharmaceutically acceptable salt form thereof.
A substantially pure compound of formula (IV),
- or a pharmaceutically acceptable salt form thereof.
A substantially pure compound of formula (V),
- or a pharmaceutically acceptable salt form thereof.
A substantially pure compound of formula (VI),
- or a pharmaceutically acceptable salt form thereof.
Dependencies are inferred from the claim text.